塩野義製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/09 | 6,468 | 6,565 | 6,454 | 6,564 | +16 | +0.2% | 667,200 |
| 2024/09/06 | 6,526 | 6,582 | 6,501 | 6,548 | -13 | -0.2% | 676,200 |
| 2024/09/05 | 6,550 | 6,626 | 6,515 | 6,561 | -69 | -1% | 710,100 |
| 2024/09/04 | 6,600 | 6,709 | 6,585 | 6,630 | -27 | -0.4% | 1,048,800 |
| 2024/09/03 | 6,570 | 6,679 | 6,562 | 6,657 | +54 | +0.8% | 655,800 |
| 2024/09/02 | 6,799 | 6,824 | 6,589 | 6,603 | -204 | -3% | 1,333,300 |
| 2024/08/30 | 6,794 | 6,843 | 6,716 | 6,807 | +37 | +0.5% | 1,840,400 |
| 2024/08/29 | 6,710 | 6,785 | 6,705 | 6,770 | +80 | +1.2% | 618,200 |
| 2024/08/28 | 6,667 | 6,708 | 6,644 | 6,690 | +37 | +0.6% | 522,900 |
| 2024/08/27 | 6,626 | 6,683 | 6,602 | 6,653 | +77 | +1.2% | 577,400 |
| 2024/08/26 | 6,599 | 6,599 | 6,516 | 6,576 | -74 | -1.1% | 838,300 |
| 2024/08/23 | 6,771 | 6,815 | 6,643 | 6,650 | -76 | -1.1% | 782,700 |
| 2024/08/22 | 6,570 | 6,749 | 6,565 | 6,726 | +122 | +1.8% | 913,900 |
| 2024/08/21 | 6,578 | 6,666 | 6,571 | 6,604 | -20 | -0.3% | 544,400 |
| 2024/08/20 | 6,588 | 6,649 | 6,515 | 6,624 | +130 | +2% | 815,400 |
| 2024/08/19 | 6,544 | 6,585 | 6,459 | 6,494 | -40 | -0.6% | 589,500 |
| 2024/08/16 | 6,452 | 6,543 | 6,415 | 6,534 | +112 | +1.7% | 722,900 |
| 2024/08/15 | 6,358 | 6,444 | 6,341 | 6,422 | +90 | +1.4% | 740,600 |
| 2024/08/14 | 6,354 | 6,360 | 6,209 | 6,332 | +9 | +0.1% | 996,900 |
| 2024/08/13 | 6,235 | 6,330 | 6,191 | 6,323 | +48 | +0.8% | 1,639,400 |
| 2024/08/09 | 6,340 | 6,403 | 6,182 | 6,275 | +35 | +0.6% | 1,341,600 |
| 2024/08/08 | 6,168 | 6,370 | 6,158 | 6,240 | -28 | -0.4% | 786,600 |
| 2024/08/07 | 6,050 | 6,491 | 6,041 | 6,268 | +109 | +1.8% | 1,550,100 |
| 2024/08/06 | 6,140 | 6,304 | 6,014 | 6,159 | +312 | +5.3% | 1,850,800 |
| 2024/08/05 | 6,250 | 6,338 | 5,834 | 5,847 | -523 | -8.2% | 2,395,700 |
| 2024/08/02 | 6,223 | 6,418 | 6,215 | 6,370 | -53 | -0.8% | 1,403,700 |
| 2024/08/01 | 6,549 | 6,570 | 6,334 | 6,423 | -174 | -2.6% | 1,126,900 |
| 2024/07/31 | 6,585 | 6,629 | 6,495 | 6,597 | +30 | +0.5% | 1,603,400 |
| 2024/07/30 | 6,493 | 6,569 | 6,403 | 6,567 | -239 | -3.5% | 2,360,800 |
| 2024/07/29 | 6,820 | 6,887 | 6,782 | 6,806 | +59 | +0.9% | 885,100 |
| 2024/07/26 | 6,737 | 6,809 | 6,728 | 6,747 | +42 | +0.6% | 942,700 |
| 2024/07/25 | 6,745 | 6,796 | 6,672 | 6,705 | -28 | -0.4% | 1,062,100 |
| 2024/07/24 | 6,822 | 6,857 | 6,721 | 6,733 | -159 | -2.3% | 896,500 |
| 2024/07/23 | 6,850 | 6,917 | 6,817 | 6,892 | +122 | +1.8% | 1,453,900 |
| 2024/07/22 | 6,750 | 6,772 | 6,678 | 6,770 | +14 | +0.2% | 897,100 |
| 2024/07/19 | 6,620 | 6,761 | 6,614 | 6,756 | +39 | +0.6% | 940,500 |
| 2024/07/18 | 6,637 | 6,780 | 6,625 | 6,717 | +92 | +1.4% | 1,035,800 |
| 2024/07/17 | 6,584 | 6,649 | 6,541 | 6,625 | +25 | +0.4% | 896,000 |
| 2024/07/16 | 6,642 | 6,671 | 6,583 | 6,600 | -43 | -0.6% | 955,800 |
| 2024/07/12 | 6,635 | 6,729 | 6,604 | 6,643 | -47 | -0.7% | 1,753,900 |
| 2024/07/11 | 6,548 | 6,718 | 6,540 | 6,690 | +228 | +3.5% | 1,957,800 |
| 2024/07/10 | 6,401 | 6,489 | 6,363 | 6,462 | +86 | +1.3% | 1,426,900 |
| 2024/07/09 | 6,283 | 6,379 | 6,262 | 6,376 | +79 | +1.3% | 1,558,700 |
| 2024/07/08 | 6,221 | 6,299 | 6,215 | 6,297 | +69 | +1.1% | 1,192,700 |
| 2024/07/05 | 6,220 | 6,262 | 6,201 | 6,228 | +32 | +0.5% | 821,700 |
| 2024/07/04 | 6,197 | 6,225 | 6,184 | 6,196 | +2 | ±0% | 702,700 |
| 2024/07/03 | 6,190 | 6,226 | 6,160 | 6,194 | -34 | -0.5% | 1,159,200 |
| 2024/07/02 | 6,245 | 6,259 | 6,188 | 6,228 | -4 | -0.1% | 1,223,300 |
| 2024/07/01 | 6,278 | 6,327 | 6,203 | 6,232 | -45 | -0.7% | 1,011,900 |
| 2024/06/28 | 6,278 | 6,290 | 6,239 | 6,277 | +21 | +0.3% | 1,560,100 |
51～
100
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 大塚ＨＤ | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム
